Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-414-9 | CAS number: 95-38-5
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The substance has an affinity for fatty tissues however does not bioaccumulate due to metabolic breakdown.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The substance has a high pKa value and is therefore protonated at physiological pH (see attached document). The protonated substance has a log Koc of 4.01 and therefore shows a moderate affinity for the compartment of the fatty tissues. The molecule contains several sites for metabolism (e.g. for hydrolysis, oxidation) and allows ring opening and degradation of the aliphatic chains. It is therefore considered that both metabolic conversion (which is lowering the Koc) and metabolic breakdown counteract to the trend for bioaccumulation. In summary the substance is unlikely to bioaccumulate.
The substance applied orally interacts with the tissues of the gastrointestinal tract and due to its high pKa value locally distorts hemostasis. This effect is likely responsible for the local effects observed in the gastrointestinal tract. Due to the increase of pH along the gastrointestinal tract from stomach (pH < 4) to duodenum (pH 8.3) an increasing amount (~ +80%) of the subtance becomes available in the non-protonated form (see attached calculation). Neutralization of the molecule favours its passage through the mucous membrane in the upper gastrontestinal tract. Following absorption the pH drops again to the value of the plasma (pH 7.4) and may be responsible for systemic & local effects.
Metabolism: The substance is considered to be susceptible for oxidation at the double bond of the aliphatic chain and at the nitrogen atoms of the ring. This leads to ring opening and subsequent breakdown of the molecule.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
